Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunologic mechanisms in psoriasis.

A B Gottlieb1

  • 1Laboratory for Investigative Dermatology, Rockefeller University, New York, New York 10021, USA.

The Journal of Investigative Dermatology
|November 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Health-related quality of life in patients with generalized pustular psoriasis: A systematic literature review.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate-to-severe plaque psoriasis: results from EXCEED, a randomized, double-blind head-to-head monotherapy study.

The British journal of dermatology·2021
Same author

Long-term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3-year results from two randomized phase III trials (CIMPASI-1 and CIMPASI-2).

The British journal of dermatology·2020
Same author

Long-term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo-controlled studies.

The British journal of dermatology·2020
Same author

Sustained efficacy of secukinumab in patients with moderate-to-severe palmoplantar psoriasis: 2·5-year results from GESTURE, a randomized, double-blind, placebo-controlled trial.

The British journal of dermatology·2019
Same author

Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.

The British journal of dermatology·2019
Same journal

Residual CSB activity explains mild UV-sensitive syndrome phenotype caused by CSB mutations.

The Journal of investigative dermatology·2026
Same journal

Human keratinocytes and fibroblasts coordinate early cutaneous innate defenses against Candida auris.

The Journal of investigative dermatology·2026
Same journal

Merkel cells attenuate autoantigen-specific T cell driven skin inflammation in mice associated with reduced neutrophil recruitment.

The Journal of investigative dermatology·2026
Same journal

The response of human melanocytic nevi to simulated solar radiation assessed by single-nucleus RNA sequencing of frozen tissue.

The Journal of investigative dermatology·2026
Same journal

Impact of Online vs In-Person Management of Atopic Dermatitis on Quality of Life and Access to Care: A Randomized Controlled Trial.

The Journal of investigative dermatology·2026
Same journal

Daratumumab as a therapeutic option for rituximab-recalcitrant pemphigus.

The Journal of investigative dermatology·2026
See all related articles

Psoriasis pathogenesis involves immune cells and cytokines. Interleukin-6 (IL-6) and gamma interferon (IFN-γ) contribute to epidermal hyperplasia and inflammation in psoriatic plaques.

Area of Science:

  • Immunology
  • Dermatology
  • Cell Biology

Background:

  • Psoriasis is a chronic inflammatory skin condition.
  • Immune system dysregulation is implicated in its development.
  • Key cellular and molecular players in psoriatic plaques are being identified.

Purpose of the Study:

  • To investigate the role of immunologic mechanisms in psoriasis pathogenesis.
  • To explore the link between epidermal hyperplasia, inflammation, and cytokines in psoriasis.
  • To determine the specific contributions of cytokines like IL-6 and IFN-γ.

Main Methods:

  • Analysis of activated T lymphocytes, keratinocytes (HLA-DR+, I-CAM 1+, gamma IP-10+), and lymphokines in psoriatic plaques.
  • Assessment of epidermal hyperplasia and acanthosis.

Related Experiment Videos

  • Detection of cytokine levels, including transforming growth factor-alpha (TGF-α) and interleukin-6 (IL-6).
  • In vitro studies on cultured keratinocytes treated with IL-6 and IFN-γ.

    • Main Results:

    • Activated immune cells and specific keratinocyte markers were found in active psoriatic lesions.
    • Increased levels of lymphokines, IL-6, and TGF-α were detected in psoriatic plaques.
    • IL-6 and IFN-γ were shown to increase TGF-α expression in keratinocytes.
    • Epidermal hyperplasia and inflammation in psoriasis appear linked to cytokine activity.

    Conclusions:

    • Immunologic mechanisms, particularly involving cytokines, are crucial in psoriasis pathogenesis.
    • Overexpression of IL-6 in psoriatic tissue may drive keratinocyte proliferation and inflammation.
    • Cytokines produced during immune activation contribute to epidermal hyperplasia in psoriasis.